Workflow
ProKidney(PROK)
icon
Search documents
ProKidney(PROK) - 2023 FY - Earnings Call Transcript
2023-09-11 17:15
ProKidney (PROK) FY 2023 Conference September 11, 2023 12:15 PM ET Speaker0 Okay. Welcome, everyone. Let's go ahead and get started. This is the fireside chat with ProKidney. My name is Vikram Prohut. I'm one of the biotech analysts with the research team. Before we get started, I need to read a brief disclosure statement. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganfamily.com/researchdisclosures. And if you have any questions, please reach out to your M ...
ProKidney(PROK) - 2023 Q2 - Quarterly Report
2023-08-09 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40560 ProKidney Corp. (Exact Name of Registrant as Specified in its Charter) | Cayman Islands | 98-1586514 | | --- | --- | | ( Sta ...
ProKidney(PROK) - 2023 Q1 - Quarterly Report
2023-05-10 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40560 ProKidney Corp. (Exact Name of Registrant as Specified in its Charter) FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 | Cayman Islands | 98-1586514 | | --- | --- | | ( St ...
ProKidney(PROK) - 2022 Q4 - Annual Report
2023-03-27 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40560 ProKidney Corp. (Exact name of Registrant as specified in its Charter) Cayman Islands 98-1586514 (State or other jurisdiction o ...
ProKidney(PROK) - 2022 Q3 - Quarterly Report
2022-11-13 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40560 ProKidney Corp. (Exact Name of Registrant as Specified in its Charter) Cayman Islands 98-1586514 ( State or other juris ...
ProKidney(PROK) - 2022 Q2 - Quarterly Report
2022-08-11 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40560 PROKIDNEY CORP. (Exact Name of Registrant as Specified in Its Charter) Cayman Islands 98-1586514 (State or ...
ProKidney(PROK) - 2022 Q1 - Quarterly Report
2022-05-15 16:00
Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION For the transition period from to Commission file number: 001-40560 SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III (Exact Name of Registrant as Specified in Its Charter) Cayman I ...
ProKidney(PROK) - 2021 Q4 - Annual Report
2022-03-23 16:00
For the transition period from to Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (650) 521-9007 (Registrant's telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Commission Fil ...
ProKidney(PROK) - 2021 Q3 - Quarterly Report
2021-11-14 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) Commission file number: 001-40560 SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III (Exact Name of Registrant as Specified in Its Charter) Cayman Islands 98-1586514 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 2850 W. Horizon Ridge Parkway, Suite 200 Henderson, NV 89052 (Address of principal executive offices) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 ...
ProKidney(PROK) - 2021 Q2 - Quarterly Report
2021-08-15 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40560 SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III (Exact Name of Registrant as Specified in Its Charter) Cayman Islands 98- ...